Focus on Patients

31. Why Diversity Of Geography Matters: A Call To Drive Rural Patient Enrollment 9/30/2024

    To make clinical trials more inclusive, CROs and sponsors must intentionally expand to different — including rural — communities to recruit more diverse patients.

32. Why Industry Must Design Alzheimer's Trials To Include People With Down Syndrome 9/24/2024

    The recruitment and enrollment of people with Down syndrome involve special challenges, but these challenges can be addressed with proper planning and education.

33. Patients Get More Mileage With Free Flights To Far-Flung Clinical Trial Sites 9/20/2024

    LifeLine Pilot Executive Director Lindsey Kerr shares the impact free medical flights can have on patients participating in clinical trials far from home.

34. Why Is The Reality Of Patient Engagement Not Living Up To Its Theory? 9/17/2024

    Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.

35. If Sponsors Invite Patients To See The Final Draft Protocol, It's Already Too Late 9/17/2024

    Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).

36. Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials? 9/13/2024

    Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.

37. 4 Steps To Help Sponsors Return Individual Patient Data 9/10/2024

    In part two of this series on individual patient data return (iPDR), Legacy Health Strategies experts offer four steps to help sponsors make iPDR a reality.

38. Returning Individual Trial Data To Patients: How And Why It Needs To Happen 9/9/2024

    Returning individual data to clinical trial participants is seen by many as "the right thing to do." Yet, its uptake is lacking. Legacy Health Strategies experts discuss why it's so important and how it can be achieved in part one of this two-part series.

39. Which Top HEOR Trends Will Have The Biggest Impact On Clinical Research? 9/6/2024

    ISPOR CEO Rob Abbott discusses Health Economics and Outcomes Research (HEOR) trends and how they're impacting clinical trials. 

40. Pelage Embraces Diverse Patient Recruitment For Non-Hormonal Hair Loss Therapy 9/5/2024

    Pelage Pharmaceuticals’ CMO Qing Yu Christina Weng, MD discusses how the company expanded criteria to include patients of all skin and hair types and incorporate decentralized elements in their trial design for a novel hair loss treatment.